Daiichi Sankyo Pfaffenhofen investment: Japanese pharma confirms €1 billion expansion in Bavaria Daiichi Sankyo confirms €1 billion investment to expand its Pfaffenhofen cancer drug site in Bavaria, keeping plans despite …
The Berlin Herald @2020 – All Right Reserved.